Clinical Trial

Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

Unknown
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the efficacy, cosmetic acceptability and improvement of the stigmatization of the tested product (2039125 03) used bis in die (BID) for 3 months in adult patients suffering from mild to moderate melasma, or mild to moderate acne induced post-inflammatory hyperpigmentation, or solar lentigo.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06268496
Lead Sponsor Cosmetique Active International
Conditions Hyperpigmentation
Enrollment 60 participants
Start Date 2024-03-14
Primary Completion 2024-07 (estimated)
Study Completion 2024-07 (estimated)
Updated on ClinicalTrials.gov 2024-07-12